Targeting RTN4/NoGo-Receptor reduces levels of ALS protein ataxin-2 is a research paper published in Cell Reports (2022). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIA
Grant: R01AG064690
Maze Therapeutics
Grant: 63/388,086
Maze Therapeutics
Grant: AXER-204
NINDS
Grant: R35NS097263
National Institutes of Health
Grant: F31NS125681
National Institutes of Health
Grant: F32NS116208
National Institutes of Health
Grant: R35NS097283
National Institutes of Health
Grant: T32AG047126
National Institutes of Health
Grant: T32NS007280
NIA NIH HHS
Grant: RF1 AG064690
NCATS NIH HHS
Grant: UL1 TR001863
National Institutes of Health
Grant: 3R35NS097263-06S1
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
National Institutes of Health
Grant: 1R35NS097283-01
Genome-Wide Discovery and Translational Research for Neural Repair
National Institutes of Health
Grant: 2T32AG047126-06A1
Stanford Training Program in Aging Research
National Institutes of Health
Grant: 2R01AG064690-02
Defining modifiers and mechanisms of RAN translation
National Institutes of Health
Grant: 1F31NS125681-01
A Novel Genome-Wide Screen to Identify and Characterize Regulators of ALS Disease Modifier Gene Ataxin-2
National Institutes of Health
Grant: 5F32NS116208-02
Deciphering the role of Ataxin-2 in amyotrophic lateral sclerosis
National Institutes of Health
Grant: 5T32NS007280-23
Epilepsy Training Program
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals